GSH/GSSG (% Control) |
---|
TIME (Day) | 1 | 2 | 3 |
---|
CTRL | 100 *** | 100** | 100 *** |
HIV | 51 ± 6.2 § | 46 ± 6.3§ | 35 ± 2.8 § |
HIV + NAC | 72 ± 4.3 | 68 ± 8.7 | 48 ± 5.1 |
- The GSH/GSSG ratio, in U373 exposed to HIV-1 IIIB, decreases compared with control of not HIV-1 exposed cells. The ratio significantly increased with NAC treatment. *p < 0.05, **p < 0.01, ***p < 0.001 when compared vs control; §p < 0.05, §§ p < 0.01, §§§ p < 0.001, when compared vs HIV.